Discussion document for the multistakeholders meeting on pharmaceuticals ( Meeting DG GROW 12th September 2017
…
Health policies in the EU aim to increase the healthy life expectancy of
…
https://www.inami.fgov.be/SiteCollectionDocuments/innovative_medicines_with_budgetary_limitations.docx
The use of real world data throughout
an innovative medicine’s lifecycle
…
The challenge for health policies is to provide high quality of care for all, within a sustainable health
…
https://www.inami.fgov.be/SiteCollectionDocuments/real_world_data.docx
Responsible editor : J. De Cock, Avenue de Tervueren 211, 1150 Bruxelles Why electronic prescriptions
…
Electronic prescribing of medicines has many benefits: } Right from the beginning
…
https://www.inami.fgov.be/SiteCollectionDocuments/brochure_prescribed_electronically.pdf
Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study K.F. Rabe*, P.A. Vermeire # , J.B. Soriano + , W.C. Maier + Clinical management of asthma
…
https://www.inami.fgov.be/SiteCollectionDocuments/clinical-management-asthma-1999.pdf
“Dure” geneesmiddelen - nominatieve lijst van de geneesmiddelenklassen, overeen gekomen in de overeenkomstencommissie - Derogatie op de tarifering per eenheid per week toegelaten
…
https://www.inami.fgov.be/SiteCollectionDocuments/lijst_nominatieve_TPE_geneesmiddelen.pdf
M.O.R.S.E sem integr report 2008 (2) – data 2nd semester 2008 DEPARTMENT OF MEDICAL CARE – MORSE project Page 1 of 48 Monitoring Of Reimbursement Significant Expenses
…
https://www.inami.fgov.be/SiteCollectionDocuments/morse-report-2008-second-semester.pdf
9$;
$
: I + <
$ $
$
? <
$
: A : F J D I
…
https://www.inami.fgov.be/SiteCollectionDocuments/morse-report-2009.pdf
B A ! 9
9 C ’ 9A ! B
A
D
A A "
D D A
B *A %% E BA A
D A
! "
A
…
https://www.inami.fgov.be/SiteCollectionDocuments/morse-report-2010.pdf
OVERVIEW OF GLOBAL EXPENDITURE ON PHARMACEUTICAL SPECIALTIES, BROKEN DOWN INTO PUBLIC PHARMACIES AND HOSPITALS
…
EXPENDITURE ON MEDICINES IN HOSPITALS: BREAKDOWN BY TYPE OF PATIENT
…
https://www.inami.fgov.be/SiteCollectionDocuments/morse-report-2019.pdf
M O R S E r e p o r t 2 0 2 1 ( 2 0 2 0 d a t a ) M o n i t o r i n g O f R e i m b u r s e m e n t S i g n i f i c a n t E x p e n s e sCONTENTS INTRODUCTION
…
https://www.inami.fgov.be/SiteCollectionDocuments/morse_report_2020.pdf
string;#2023.06.1 Liste spécialités pharmaceutiques - 01/06/2023 - Lijst farmaceutische specialiteiten
https://www.inami.fgov.be/SiteCollectionDocuments/liste-specialites-20230601.xlsx
Bijwerking 01.06.2023 - Mise à jour 01.06.2023 I
…
I = Aandeel van de rechthebbenden bedoeld in artikel 37, §1 en §19, van de bij het koninklijk besluit van 14.7.94 gecoördineerde wet
…
https://www.inami.fgov.be/SiteCollectionDocuments/liste_specialites_chapter1_20230601.pdf
Rapport d’analyse globale du contenu de Pharmanet – piste unique 2009 Unité de gestion Politique pharmaceutique Service des Soins de Santé Ce « Rapport d’analyse
…
https://www.inami.fgov.be/SiteCollectionDocuments/analyticalreport.pdf
ROYAUME DE BELGIQUE KONINKRIJK BELGIE MINISTERE DES AFFAIRES SOCIALES, DE LA SANTE PUBLIQUE ET DE L'ENVIRONNEMENT MINISTERIE VAN SOCIALE ZAKEN, VOLKSGEZONDHEID EN LEEFMILIEU
…
https://www.inami.fgov.be/SiteCollectionDocuments/AR20011221-commission-remboursement-medicaments.pdf
Ci-dessous, vous pouvez prendre connaissance de ces montants; comme vous pouvez le constater, nous avons mentionné dans chaque tableau la référence aux textes réglementaires
…
https://www.inami.fgov.be/SiteCollectionDocuments/bi2015_4_donnees_base_I_assurance_continuee.pdf